Special Issue "Therapeutics Delivery Systems for Regenerative Nanomedicine"
A special issue of Materials (ISSN 1996-1944).
Deadline for manuscript submissions: closed (31 August 2015)
Dr. Nadia Jessel
While the aim of tissue engineering (TE) is to produce biological substitutes of failing organs, regenerative medicine is dedicated to restoring tissue function, and uses several methods to achieve this goal (for instance, gene therapy or nanomedicine). The two fields are merging today, and constitute a strongly interdisciplinary domain called TERM (Tissue Engineering and Regenerative Medicine).
Cell-based therapies are growing as strategies for tissue repair, but the important drawback remains the tuning of the microenvironments of these delivered cells. Some cell-based therapies for tissue repair have been used without cell carriers, but long term cell grafting has proven to be more efficacious in the presence of an appropriate biomaterial. The ideal biomaterial carrier should enable cell integration, differentiation, and proliferation within the wounded host tissue, regeneration into normal tissue through healing, and restore function. In this environment, many cues will trigger the physiological processes of tissue regeneration: receptors, growth factors, vascularization, and proteases. In addition, one can further enhance biomaterial scaffolds' functionalities by integrating other therapeutics, and there is growing interest in drug delivery applications in tissue engineering. This field is called TE therapeutics.
In this Special Issue, we address the various aspects involved in the improvement of tissue repair through the elaboration of therapeutics delivery systems.
It is my pleasure to invite you to submit a manuscript for this Special Issue. Full papers, communications, and reviews are all welcome.
Dr. Nadia Jessel
Dr. Pascale Schwinté
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Materials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery systems
- controlled release
- sustained release
- targeted delivery
- regenerative nanomedicine